
API China 2026 Shanghai | Pharma Ingredients & Biopharma Expo
Meet 1,200+ exhibitors and 60,000 pharma professionals in Shanghai, May 13–15, 2026. Explore APIs, biopharma and packaging. Register for a free ticket.
China Business Forum#CPHI &
#PMEC #China 2026 is scheduled to be held from June 16 to 18, 2026, at the
#Shanghai New
#International #Expo #Centre. The
#event, recognized as
#Asia’s largest
#pharmaceutical #trade #show, will build on its previous successes, with expectations of over 110,000
#attendees and more than 3,600
#exhibitors from local and international
#markets.
https://cnbusinessforum.com/cphi-pmec-china-2026-to-host-asias-largest-pharma-event-in-shanghai/ 
CPHI & PMEC China 2026: Shanghai Pharma Trade Show (SNIEC)
CPHI & PMEC China 2026 runs June 16–18 at SNIEC Shanghai, with 3,600+ exhibitors, 110,000+ attendees, and 100+ conferences across pharma supply.
China Business Forum
CPHI & PMEC China 2026 | Pharma Manufacturing Expo Shanghai
Join 110,000+ pharma professionals and 3,600 exhibitors in Shanghai, June 16–18, 2026. Discover APIs, machinery and biotech innovation. Register for a free ticket.
China Business Forum
API China 2026 Shanghai | Pharma Ingredients & Biopharma Expo
Meet 1,200+ exhibitors and 60,000 pharma professionals in Shanghai, May 13–15, 2026. Explore APIs, biopharma and packaging. Register for a free ticket.
China Business ForumResearchers identified a novel type of protein modification driven by mutations in the isocitrate dehydrogenase enzyme, which fundamentally alters how kinase enzymes regulate cellular energy and protein function during cancer development.
#Biochemistry #Oncology #Pharmaceutical #sflorghttps://www.sflorg.com/2026/03/bchm03252602.html
Protein modification discovery opens cancer therapy possibilities
A new type of protein modification related to cellular mutation that impairs a crucial enzyme’s ability to help drive energy processes.
Researchers have designed a novel family of antiviral molecules—sugar-derived aziridines based on the structure of oseltamivir (Tamiflu)—that effectively bind to and inhibit neuraminidase, a key surface protein required for the spread of the influenza virus.
#Virology #Pharmaceutical #Biochemistry #Chemistry #sflorghttps://www.sflorg.com/2026/03/vi03242601.html
New compounds to inactivate a key protein in the influenza virus
Neuraminidase (NA) is one of the key surface enzymes of the influenza virus
#CPHI &
#PMEC #China 2026 is scheduled to be held from June 16 to 18, 2026, at the
#Shanghai New
#International #Expo #Centre. The
#event, recognized as
#Asia’s largest
#pharmaceutical #trade #show, will build on its previous successes, with expectations of over 110,000
#attendees and more than 3,600
#exhibitors from local and international
#markets.
https://cnbusinessforum.com/cphi-pmec-china-2026-to-host-asias-largest-pharma-event-in-shanghai/ 
CPHI & PMEC China 2026: Shanghai Pharma Trade Show (SNIEC)
CPHI & PMEC China 2026 runs June 16–18 at SNIEC Shanghai, with 3,600+ exhibitors, 110,000+ attendees, and 100+ conferences across pharma supply.
China Business Forum
CPHI & PMEC China 2026 | Pharma Manufacturing Expo Shanghai
Join 110,000+ pharma professionals and 3,600 exhibitors in Shanghai, June 16–18, 2026. Discover APIs, machinery and biotech innovation. Register for a free ticket.
China Business Forum